Crosstec Group Holdings Limited (HKG:3893)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions HKD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	36	90	37	54	238	118
Market Cap Growth	53.60%	142.79%	-31.20%	-77.27%	101.22%	-7.17%
Enterprise Value	115	126	81	65	241	101
Last Close Price	0.15	0.58	0.43	0.70	3.08	1.53
PS Ratio	0.38	1.22	0.77	1.35	2.74	2.19
PB Ratio	-0.62	-2.03	-0.69	-4.35	32.68	6.18
P/TBV Ratio	-	-	-	-	32.68	6.18
EV/Sales Ratio	1.25	1.71	1.68	1.61	2.79	1.88
Debt / Equity Ratio	-1.50	-1.91	-1.44	-2.83	2.58	0.89
Asset Turnover	1.46	1.20	0.89	0.82	1.67	0.92
Quick Ratio	0.79	0.64	0.63	0.77	0.63	1.04
Current Ratio	0.83	0.74	0.81	1.01	0.91	1.47
Return on Equity (ROE)	-	-	-	-	-89.49%	-101.57%
Return on Assets (ROA)	-23.06%	-9.66%	-48.34%	-23.36%	-16.21%	-21.55%
Return on Capital (ROIC)	-38.08%	-18.58%	-112.41%	-46.53%	-27.01%	-34.63%
Earnings Yield	-92.12%	-14.46%	-144.15%	-40.53%	-4.96%	-23.89%
FCF Yield	-110.76%	-44.75%	-99.49%	-22.85%	-3.94%	-15.50%
Buyback Yield / Dilution	-26.76%	-46.03%	-27.38%	-	-15.28%	-4.10%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.